Anna Eshoo actually said...

"Because of the leadership of this committee, CMS has announced a plan change to that as of January 1."

"We need an approach that focuses on the patient and the cost to the health care system, which will be tethered by ensuring that there is sufficient competition in the market place."

"It would be nice if we could come up with a simplified system for drug pricing and perhaps this hearing will begin that."

"Congresswoman Eshoo and I worked together several years ago to get a biosimilar title in what's now called the Affordable Care Act."